Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Repayments (2012 - 2025)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Long-Term Debt Repayments of $9.6 million for Q1 2025, up 4006.38% year-over-year from $235000.0 in Q1 2024, and up 1268.79% quarter-over-quarter from $705000.0 in Q4 2024.
Tonix Pharmaceuticals Holding (TNXP) Long-Term Debt Repayments (2012 - 2025) Analysis & Trends
Tonix Pharmaceuticals Holding's Long-Term Debt Repayments history runs 3 years deep, the most recent figure standing at $9.6 million for Q1 2025.
- In Q1 2025, Long-Term Debt Repayments rose 4006.38% year-over-year to $9.6 million; the TTM figure through Dec 2025 stood at $9.6 million (up 310.64% YoY), while the FY2025 annual figure was $9.6 million, up 310.64% from the prior year.
- Long-Term Debt Repayments for Q1 2025 stood at $9.6 million, up from $705000.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $9.6 million in Q1 2025, with the low at $235000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 17.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 50,000.00 |
| Jun 30, 2025 | 50,000.00 |
| Mar 31, 2025 | 9.65 Mn |
| Mar 31, 2025 | 9.65 Mn |
| Dec 31, 2024 | 705,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 705,000.00 |
| Sep 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Mar 31, 2024 | 235,000.00 |
| Mar 31, 2012 | 150,000.00 |
| Mar 31, 2012 | 150,000.00 |